ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meningococcal Vaccine Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-11140
Home | Market Reports
Global Meningococcal Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Meningococcal Vaccine Market Research Report 2026

Code: QYRE-Auto-11140
Report
2026-02-03
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
GSK
Merck
CSL Limited
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
Hualan Bio
Walvax
Zhifei
China
China National Biotec Group

Meningococcal Vaccine Market Size

The global Meningococcal Vaccine market was valued at US$ 297 million in 2025 and is anticipated to reach US$ 399 million by 2032, at a CAGR of 4.4% from 2026 to 2032.

Meningococcal Vaccine Market

Meningococcal Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Meningococcal Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%. Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent. In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.
This report delivers a comprehensive overview of the global Meningococcal Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Meningococcal Vaccine. The Meningococcal Vaccine market size, estimates, and forecasts are provided in terms of sales volume (10K Pcs) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Meningococcal Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Meningococcal Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Meningococcal Vaccine Market Report

Report Metric Details
Report Name Meningococcal Vaccine Market
Accounted market size in 2025 US$ 297 million
Forecasted market size in 2032 US$ 399 million
CAGR 4.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Meningtits A
  • Polysaccharide Meningtitis AC
  • Meningitis ACYW
by Application
  • 6 Months-15Year
  • over 3 Year
  • over 2 Year
  • over 3 Months
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Walvax, Zhifei
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Meningococcal Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Meningococcal Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Meningococcal Vaccine Market growing?

Ans: The Meningococcal Vaccine Market witnessing a CAGR of 4.4% during the forecast period 2026-2032.

What is the Meningococcal Vaccine Market size in 2032?

Ans: The Meningococcal Vaccine Market size in 2032 will be US$ 399 million.

What is the market share of major companies in Meningococcal Vaccine Market?

Ans: Global top five players hold a share about 80%.

What is the Meningococcal Vaccine Market share by type?

Ans: In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%.

Who are the main players in the Meningococcal Vaccine Market report?

Ans: The main players in the Meningococcal Vaccine Market are Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Walvax, Zhifei

What are the Application segmentation covered in the Meningococcal Vaccine Market report?

Ans: The Applications covered in the Meningococcal Vaccine Market report are 6 Months-15Year, over 3 Year, over 2 Year, over 3 Months

What are the Type segmentation covered in the Meningococcal Vaccine Market report?

Ans: The Types covered in the Meningococcal Vaccine Market report are Meningtits A, Polysaccharide Meningtitis AC, Meningitis ACYW

1 Meningococcal Vaccine Market Overview
1.1 Product Definition
1.2 Meningococcal Vaccine by Type
1.2.1 Global Meningococcal Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Meningtits A
1.2.3 Polysaccharide Meningtitis AC
1.2.4 Meningitis ACYW
1.3 Meningococcal Vaccine by Application
1.3.1 Global Meningococcal Vaccine Market Value by Application: 2025 vs 2032
1.3.2 6 Months-15Year
1.3.3 over 3 Year
1.3.4 over 2 Year
1.3.5 over 3 Months
1.4 Global Meningococcal Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Vaccine Revenue 2021–2032
1.4.2 Global Meningococcal Vaccine Sales 2021–2032
1.4.3 Global Meningococcal Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Meningococcal Vaccine Market Competition by Manufacturers
2.1 Global Meningococcal Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Meningococcal Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Meningococcal Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Meningococcal Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Meningococcal Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Meningococcal Vaccine, Date of Entry into the Industry
2.8 Global Meningococcal Vaccine Market Competitive Situation and Trends
2.8.1 Global Meningococcal Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Meningococcal Vaccine Players Market Share by Revenue
2.8.3 Global Meningococcal Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meningococcal Vaccine Market Scenario by Region
3.1 Global Meningococcal Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Meningococcal Vaccine Sales by Region: 2021–2032
3.2.1 Global Meningococcal Vaccine Sales by Region: 2021–2026
3.2.2 Global Meningococcal Vaccine Sales by Region: 2027–2032
3.3 Global Meningococcal Vaccine Revenue by Region: 2021–2032
3.3.1 Global Meningococcal Vaccine Revenue by Region: 2021–2026
3.3.2 Global Meningococcal Vaccine Revenue by Region: 2027–2032
3.4 North America Meningococcal Vaccine Market Facts & Figures by Country
3.4.1 North America Meningococcal Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Meningococcal Vaccine Sales by Country (2021–2032)
3.4.3 North America Meningococcal Vaccine Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meningococcal Vaccine Market Facts & Figures by Country
3.5.1 Europe Meningococcal Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Meningococcal Vaccine Sales by Country (2021–2032)
3.5.3 Europe Meningococcal Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meningococcal Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Meningococcal Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Meningococcal Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Meningococcal Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Meningococcal Vaccine Market Facts & Figures by Country
3.7.1 Latin America Meningococcal Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Meningococcal Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Meningococcal Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meningococcal Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Meningococcal Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Meningococcal Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Meningococcal Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meningococcal Vaccine Sales by Type (2021–2032)
4.1.1 Global Meningococcal Vaccine Sales by Type (2021–2026)
4.1.2 Global Meningococcal Vaccine Sales by Type (2027–2032)
4.1.3 Global Meningococcal Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Meningococcal Vaccine Revenue by Type (2021–2032)
4.2.1 Global Meningococcal Vaccine Revenue by Type (2021–2026)
4.2.2 Global Meningococcal Vaccine Revenue by Type (2027–2032)
4.2.3 Global Meningococcal Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Meningococcal Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Meningococcal Vaccine Sales by Application (2021–2032)
5.1.1 Global Meningococcal Vaccine Sales by Application (2021–2026)
5.1.2 Global Meningococcal Vaccine Sales by Application (2027–2032)
5.1.3 Global Meningococcal Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Meningococcal Vaccine Revenue by Application (2021–2032)
5.2.1 Global Meningococcal Vaccine Revenue by Application (2021–2026)
5.2.2 Global Meningococcal Vaccine Revenue by Application (2027–2032)
5.2.3 Global Meningococcal Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Meningococcal Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novartis Meningococcal Vaccine Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Meningococcal Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merck Meningococcal Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 CSL
6.4.1 CSL Company Information
6.4.2 CSL Description and Business Overview
6.4.3 CSL Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 CSL Meningococcal Vaccine Product Portfolio
6.4.5 CSL Recent Developments/Updates
6.5 Baxter
6.5.1 Baxter Company Information
6.5.2 Baxter Description and Business Overview
6.5.3 Baxter Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Baxter Meningococcal Vaccine Product Portfolio
6.5.5 Baxter Recent Developments/Updates
6.6 JN International Medical Corporation
6.6.1 JN International Medical Corporation Company Information
6.6.2 JN International Medical Corporation Description and Business Overview
6.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 JN International Medical Corporation Meningococcal Vaccine Product Portfolio
6.6.5 JN International Medical Corporation Recent Developments/Updates
6.7 Serum Institute of India
6.7.1 Serum Institute of India Company Information
6.7.2 Serum Institute of India Description and Business Overview
6.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Serum Institute of India Meningococcal Vaccine Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Company Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Bio-Med Meningococcal Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 China National Biotec Group
6.9.1 China National Biotec Group Company Information
6.9.2 China National Biotec Group Description and Business Overview
6.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 China National Biotec Group Meningococcal Vaccine Product Portfolio
6.9.5 China National Biotec Group Recent Developments/Updates
6.10 Hualan Bio
6.10.1 Hualan Bio Company Information
6.10.2 Hualan Bio Description and Business Overview
6.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hualan Bio Meningococcal Vaccine Product Portfolio
6.10.5 Hualan Bio Recent Developments/Updates
6.11 Walvax
6.11.1 Walvax Company Information
6.11.2 Walvax Description and Business Overview
6.11.3 Walvax Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Walvax Meningococcal Vaccine Product Portfolio
6.11.5 Walvax Recent Developments/Updates
6.12 Zhifei
6.12.1 Zhifei Company Information
6.12.2 Zhifei Description and Business Overview
6.12.3 Zhifei Meningococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Zhifei Meningococcal Vaccine Product Portfolio
6.12.5 Zhifei Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meningococcal Vaccine Industry Chain Analysis
7.2 Meningococcal Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meningococcal Vaccine Production Mode & Process Analysis
7.4 Meningococcal Vaccine Sales and Marketing
7.4.1 Meningococcal Vaccine Sales Channels
7.4.2 Meningococcal Vaccine Distributors
7.5 Meningococcal Vaccine Customer Analysis
8 Meningococcal Vaccine Market Dynamics
8.1 Meningococcal Vaccine Industry Trends
8.2 Meningococcal Vaccine Market Drivers
8.3 Meningococcal Vaccine Market Challenges
8.4 Meningococcal Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
GSK
Merck
CSL Limited
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
Hualan Bio
Walvax
Zhifei
China
China National Biotec Group
List of Tables
 Table 1. Global Meningococcal Vaccine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Meningococcal Vaccine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Meningococcal Vaccine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Meningococcal Vaccine Sales (10K Pcs) of Key Manufacturers (2021–2026)
 Table 5. Global Meningococcal Vaccine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Meningococcal Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Meningococcal Vaccine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Meningococcal Vaccine Average Price (USD/Pcs) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Meningococcal Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Meningococcal Vaccine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Meningococcal Vaccine, Product Types and Applications
 Table 12. Global Key Manufacturers of Meningococcal Vaccine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Meningococcal Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Meningococcal Vaccine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Meningococcal Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Meningococcal Vaccine Sales by Region (10K Pcs), 2021–2026
 Table 18. Global Meningococcal Vaccine Sales Market Share by Region (2021–2026)
 Table 19. Global Meningococcal Vaccine Sales by Region (10K Pcs), 2027–2032
 Table 20. Global Meningococcal Vaccine Sales Market Share by Region (2027–2032)
 Table 21. Global Meningococcal Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Meningococcal Vaccine Revenue Market Share by Region (2021–2026)
 Table 23. Global Meningococcal Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Meningococcal Vaccine Revenue Market Share by Region (2027–2032)
 Table 25. North America Meningococcal Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Meningococcal Vaccine Sales by Country (10K Pcs), 2021–2026
 Table 27. North America Meningococcal Vaccine Sales by Country (10K Pcs), 2027–2032
 Table 28. North America Meningococcal Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Meningococcal Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Meningococcal Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Meningococcal Vaccine Sales by Country (10K Pcs), 2021–2026
 Table 32. Europe Meningococcal Vaccine Sales by Country (10K Pcs), 2027–2032
 Table 33. Europe Meningococcal Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Meningococcal Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Meningococcal Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Meningococcal Vaccine Sales by Region (10K Pcs), 2021–2026
 Table 37. Asia Pacific Meningococcal Vaccine Sales by Region (10K Pcs), 2027–2032
 Table 38. Asia Pacific Meningococcal Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Meningococcal Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Meningococcal Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Meningococcal Vaccine Sales by Country (10K Pcs), 2021–2026
 Table 42. Latin America Meningococcal Vaccine Sales by Country (10K Pcs), 2027–2032
 Table 43. Latin America Meningococcal Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Meningococcal Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Meningococcal Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Meningococcal Vaccine Sales by Country (10K Pcs), 2021–2026
 Table 47. Middle East and Africa Meningococcal Vaccine Sales by Country (10K Pcs), 2027–2032
 Table 48. Middle East and Africa Meningococcal Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Meningococcal Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Meningococcal Vaccine Sales (10K Pcs) by Type (2021–2026)
 Table 51. Global Meningococcal Vaccine Sales (10K Pcs) by Type (2027–2032)
 Table 52. Global Meningococcal Vaccine Sales Market Share by Type (2021–2026)
 Table 53. Global Meningococcal Vaccine Sales Market Share by Type (2027–2032)
 Table 54. Global Meningococcal Vaccine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Meningococcal Vaccine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Meningococcal Vaccine Revenue Market Share by Type (2021–2026)
 Table 57. Global Meningococcal Vaccine Revenue Market Share by Type (2027–2032)
 Table 58. Global Meningococcal Vaccine Price (USD/Pcs) by Type (2021–2026)
 Table 59. Global Meningococcal Vaccine Price (USD/Pcs) by Type (2027–2032)
 Table 60. Global Meningococcal Vaccine Sales (10K Pcs) by Application (2021–2026)
 Table 61. Global Meningococcal Vaccine Sales (10K Pcs) by Application (2027–2032)
 Table 62. Global Meningococcal Vaccine Sales Market Share by Application (2021–2026)
 Table 63. Global Meningococcal Vaccine Sales Market Share by Application (2027–2032)
 Table 64. Global Meningococcal Vaccine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Meningococcal Vaccine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Meningococcal Vaccine Revenue Market Share by Application (2021–2026)
 Table 67. Global Meningococcal Vaccine Revenue Market Share by Application (2027–2032)
 Table 68. Global Meningococcal Vaccine Price (USD/Pcs) by Application (2021–2026)
 Table 69. Global Meningococcal Vaccine Price (USD/Pcs) by Application (2027–2032)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 73. Novartis Meningococcal Vaccine Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 78. GSK Meningococcal Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 83. Merck Meningococcal Vaccine Product
 Table 84. Merck Recent Developments/Updates
 Table 85. CSL Company Information
 Table 86. CSL Description and Business Overview
 Table 87. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 88. CSL Meningococcal Vaccine Product
 Table 89. CSL Recent Developments/Updates
 Table 90. Baxter Company Information
 Table 91. Baxter Description and Business Overview
 Table 92. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 93. Baxter Meningococcal Vaccine Product
 Table 94. Baxter Recent Developments/Updates
 Table 95. JN International Medical Corporation Company Information
 Table 96. JN International Medical Corporation Description and Business Overview
 Table 97. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 98. JN International Medical Corporation Meningococcal Vaccine Product
 Table 99. JN International Medical Corporation Recent Developments/Updates
 Table 100. Serum Institute of India Company Information
 Table 101. Serum Institute of India Description and Business Overview
 Table 102. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 103. Serum Institute of India Meningococcal Vaccine Product
 Table 104. Serum Institute of India Recent Developments/Updates
 Table 105. Bio-Med Company Information
 Table 106. Bio-Med Description and Business Overview
 Table 107. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 108. Bio-Med Meningococcal Vaccine Product
 Table 109. Bio-Med Recent Developments/Updates
 Table 110. China National Biotec Group Company Information
 Table 111. China National Biotec Group Description and Business Overview
 Table 112. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 113. China National Biotec Group Meningococcal Vaccine Product
 Table 114. China National Biotec Group Recent Developments/Updates
 Table 115. Hualan Bio Company Information
 Table 116. Hualan Bio Description and Business Overview
 Table 117. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 118. Hualan Bio Meningococcal Vaccine Product
 Table 119. Hualan Bio Recent Developments/Updates
 Table 120. Walvax Company Information
 Table 121. Walvax Description and Business Overview
 Table 122. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 123. Walvax Meningococcal Vaccine Product
 Table 124. Walvax Recent Developments/Updates
 Table 125. Zhifei Company Information
 Table 126. Zhifei Description and Business Overview
 Table 127. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs), and Gross Margin (2021–2026)
 Table 128. Zhifei Meningococcal Vaccine Product
 Table 129. Zhifei Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Meningococcal Vaccine Distributors List
 Table 133. Meningococcal Vaccine Customers List
 Table 134. Meningococcal Vaccine Market Trends
 Table 135. Meningococcal Vaccine Market Drivers
 Table 136. Meningococcal Vaccine Market Challenges
 Table 137. Meningococcal Vaccine Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Meningococcal Vaccine
 Figure 2. Global Meningococcal Vaccine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Meningococcal Vaccine Market Share by Type: 2025 & 2032
 Figure 4. Meningtits A Product Picture
 Figure 5. Polysaccharide Meningtitis AC Product Picture
 Figure 6. Meningitis ACYW Product Picture
 Figure 7. Global Meningococcal Vaccine Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Meningococcal Vaccine Market Share by Application: 2025 & 2032
 Figure 9. 6 Months-15Year
 Figure 10. over 3 Year
 Figure 11. over 2 Year
 Figure 12. over 3 Months
 Figure 13. Global Meningococcal Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Meningococcal Vaccine Market Size (US$ Million), 2021–2032
 Figure 15. Global Meningococcal Vaccine Sales (10K Pcs), 2021–2032
 Figure 16. Global Meningococcal Vaccine Average Price (USD/Pcs), 2021–2032
 Figure 17. Meningococcal Vaccine Report Years Considered
 Figure 18. Meningococcal Vaccine Sales Share by Manufacturers in 2025
 Figure 19. Global Meningococcal Vaccine Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Meningococcal Vaccine Players: Market Share by Revenue in Meningococcal Vaccine in 2025
 Figure 21. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Meningococcal Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Meningococcal Vaccine Sales Market Share by Country (2021–2032)
 Figure 24. North America Meningococcal Vaccine Revenue Market Share by Country (2021–2032)
 Figure 25. U.S. Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Meningococcal Vaccine Sales Market Share by Country (2021–2032)
 Figure 28. Europe Meningococcal Vaccine Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Meningococcal Vaccine Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Meningococcal Vaccine Revenue Market Share by Region (2021–2032)
 Figure 36. China Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Indonesia Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Thailand Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Malaysia Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Meningococcal Vaccine Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Meningococcal Vaccine Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Meningococcal Vaccine Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Meningococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Meningococcal Vaccine by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Meningococcal Vaccine by Type (2021–2032)
 Figure 57. Global Meningococcal Vaccine Price (USD/Pcs) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Meningococcal Vaccine by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Meningococcal Vaccine by Application (2021–2032)
 Figure 60. Global Meningococcal Vaccine Price (USD/Pcs) by Application (2021–2032)
 Figure 61. Meningococcal Vaccine Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Meningococcal Infections Vaccine Market Insights Forecast to 2030
Meningococcal Disease Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meningococcal Infections Treatment Market Research Report 2024
Meningococcal Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meningococcal Polysaccharide Vaccine Market Research Report 2025
Vaccine for Non infectious Meningitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Group A and C Meningococcal Polysaccharide Vaccine Market Research Report 2024
Meningococcal Group B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prevent Meningitis Vaccine Market Research Report 2025
Meningitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meningococcal Meningitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Research Report 2025
Global Meningococcal Group A and C Conjugate Vaccine Market Research Report 2024
Global Meningitis Vaccine Market Research Report 2025
Global Neisseria meningitidis Infections Drug Market Research Report 2024
Global Vaccines For Children Market Insights Forecast to 2030
Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Pneumococcal Vaccination Market Research Report 2025
Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meningitis Medication Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions